Potential interactions with anticancer agents: a cross-sectional study.

Abstract:

BACKGROUND:Patients with cancer are particularly susceptible to drug interactions (DIs), but the extent of the problem has received limited attention. We aimed to evaluate the frequency of interactions with anticancer agents in a group of cancer patients. METHODS:The study was performed in a Belgian teaching hospital. One hundred and twenty-two patients with solid malignancies were included. A comprehensive drug history was performed by a clinical pharmacist. Three renowned DI compendia were used to identify DIs. RESULTS:Forty-one potential interactions involving an anticancer agent and considered to be clinically significant were identified among 25% of patients. The anticancer drugs mostly involved were cisplatin and methotrexate, and the most frequent co-medications involved were vitamin K antagonists, proton pump inhibitors and diuretics. In the majority of cases, the potential adverse consequence was increased toxicity of the anticancer agent and/or of the co-medication. Less than 10% of DIs were identified by the three compendia. CONCLUSIONS:Preventive measures should be taken to avoid increased toxicity or decreased efficacy of the drugs. Most of the time, this simply involves surveillance of biological or clinical parameters. Collaboration with a clinical pharmacist may be useful for the prescribing physician.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Mouzon A,Kerger J,D'Hondt L,Spinewine A

doi

10.1159/000351133

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

85-92

issue

2

eissn

0009-3157

issn

1421-9794

pii

000351133

journal_volume

59

pub_type

杂志文章
  • Endogenous production of tumor necrosis factor alpha in combination with hyperthermia for the treatment of mice bearing Ehrlich ascites tumor.

    abstract::Multiple hyperthermia was found to exert an additive antitumor effect when combined with the in vivo production of tumor necrosis factor alpha (TNF-alpha) in mice bearing Ehrlich ascites tumor (EAT). TNF-alpha was produced in EAT-bearing mice by priming the animals with zymosan and subsequently challenging with lipopo...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239370

    authors: Wong CK,Fung KP,Kong SK,Lee CY,Choy YM

    更新日期:1995-09-01 00:00:00

  • Anticancer chemotherapy accelerates scalp hair loss with no androgenic involvement.

    abstract::The involvement of plasma testosterone in patients associated with scalp hair loss accelerated by anticancer drugs including aclarubicin and cisplatin was investigated. Scalp hair loss observed was minor in 12 and severe in 2 out of 31 patients. In patients without significant hair loss, the combination of aclarubicin...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238635

    authors: Umeki S,Niki Y,Soejima R

    更新日期:1989-01-01 00:00:00

  • Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis.

    abstract:BACKGROUND:Ginkgolic acids (GAs), extracted from the seed coat of Ginkgo biloba L. Our previous study has shown that GA monomer could inhibit the growth of Hep-2 significantly and induce the fragmentation of the chromosomal DNA. To further assess the antitumor potential and turn it into a candidate new antitumor drug, ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000317750

    authors: Zhou C,Li X,Du W,Feng Y,Kong X,Li Y,Xiao L,Zhang P

    更新日期:2010-01-01 00:00:00

  • Bactericidal activity of cefotiam and ceftizoxime against Neisseria gonorrhoeae in an in vitro model simulating plasma and cantharidal blister fluid levels after the single intramuscular application of one gram.

    abstract::Two gonococcal strains with differing susceptibility to cefotiam and ceftizoxime, as expressed by the minimum inhibitory concentration (MIC), are exposed to continuously changing concentrations of these antibiotics as they are found in plasma and skin cantharidal blister fluid (CBF) after a single intramuscular applic...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238423

    authors: Korting HC,Niederauer H,Ollert M

    更新日期:1986-01-01 00:00:00

  • Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.

    abstract:BACKGROUND:The glomerular filtration rate (GFR) is essential for calculating the dose and the monitoring of carboplatin. Although GFR measurement (mGFR) by external markers is ideal, in most cases these are not employed; the most used method is GFR estimation (eGFR) by formulae, hence the need to identify the formula w...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000488538

    authors: Graciano Vera N,Pino Villarreal L,Ureña Vargas J

    更新日期:2018-01-01 00:00:00

  • Immunotoxicity of cephalosporins in mice.

    abstract::This study was performed in female B6C3F1 mice to confirm previously observed effects of selected cephalosporin antibiotics on nonspecific immunity, and to determine possible effects on specific acquired immunity and host resistance. Mice were treated intravenously with DQ-2556, ceftizoxime or ceftezole at 800 mg/kg/d...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239137

    authors: Furuhama K,Benson RW,Knowles BJ,Roberts DW

    更新日期:1993-07-01 00:00:00

  • Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.

    abstract:BACKGROUND/AIM:A phase 3 trial of S-1, leucovorin (LV), and oxaliplatin for treating gastric cancer is now underway. However, the antitumor efficacy of the combination has not yet been examined in an in vivo preclinical study. This study examined the antitumor efficacy of combination therapy consisting of S-1, LV, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000486029

    authors: Nagase H,Nakagawa F,Uchida J

    更新日期:2018-01-01 00:00:00

  • Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.

    abstract::After intravenous bolus injection of single doses of 25, 50, 75 and 100 mg of ofloxacin (HOE 280) to 34 healthy male volunteers, concentrations of unchanged drug were estimated at various times in serum and urine over 32 and 48 h. Ofloxacin concentrations were determined using high-pressure liquid chromatography (HPLC...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238567

    authors: Verho M,Korn A,Badian M,Malerczyk V,Waldhäusl W

    更新日期:1988-01-01 00:00:00

  • Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.

    abstract::Using the biophotometer with ticarcillin no persistent bactericidal effect was found against Pseudomonas aeruginosa NCTC 10490. After addition of 1.2 microgram/ml gentamicin an increase of multiplication of bacteria was observed, but not after 1.2 microgram/ml tobramycin. With 6.2 microgram/ml tobramycin bactericidal ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222001

    authors: Ullmann U

    更新日期:1977-01-01 00:00:00

  • Treatment of twelve burn wound infections and eight other serious infections with cefazolin and tobramycin: in vitro and in vivo evaluation.

    abstract::20 patients with serious infections were treated with cefazolin and tobramycin for 9--64 days. Minimal inhibitory concentration (MIC) values and minimal bactericidal concentration (MBC) values were determined for each of the 112 clinical bacterial isolates. The median cefazolin MIC/MBC was 1.56/12.5 micrograms/ml, and...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237931

    authors: Franson TR,Edwards LD,Collins RF,Root TE

    更新日期:1980-01-01 00:00:00

  • Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum.

    abstract::A total of 1,442 patients with symptoms of chronic prostatitis were examined over a 4-year period at the Outpatient Department for Urogenital Infections, University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia. The inclusion criteria for chronic prostatitis caused by Ureaplasma urealyticum wer...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000090234

    authors: Skerk V,Mareković I,Markovinović L,Begovac J,Skerk V,Barsić N,Majdak-Gluhinić V

    更新日期:2006-01-01 00:00:00

  • Treatment of community-acquired pneumonia.

    abstract::Lower respiratory tract infections are the major cause of death due to infectious disease in the developed and developing world. Despite substantial progress in defining pathogens and in therapeutic options, there continues to be major controversies in the clinical management of these infections. This report reviews t...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000048489

    authors: Bartlett J

    更新日期:2000-01-01 00:00:00

  • Derivation of meropenem dosage in patients receiving continuous veno-venous hemofiltration based on pharmacodynamic target attainment.

    abstract:BACKGROUND:Dosage recommendations for antibiotics in patients receiving continuous veno-venous hemofiltration (CVVH) should be based on pharmacodynamic requirements. For meropenem, this would be achieving appropriate time above the minimum inhibitory concentration (T > MIC). We employed Monte Carlo simulation to calcul...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000086598

    authors: Kuti JL,Nicolau DP

    更新日期:2005-07-01 00:00:00

  • Effect of probenecid on the pharmacokinetics of DQ-2556, a new 3-quaternary ammonium cephalosporin antibiotic, in humans.

    abstract::A total of 5 healthy volunteers were enrolled in a crossover study on the dose dependency and the effect of probenecid on pharmacokinetics of DQ-2556. They were administered intravenously 0.5 and 1.0 g of DQ-2556, and 1.0 g of DQ-2556 with oral administration of probenecid. The linearity in pharmacokinetics of DQ-2556...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239029

    authors: Shiba K,Yoshida M,Shimada J,Saito A,Matsubayashi K,Hashimoto S,Yoshida K,Osada Y,Sakai O

    更新日期:1992-01-01 00:00:00

  • Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients.

    abstract::Cefpirome and six other antimicrobial agents were tested against 884 blood culture isolates from cancer patients. Cefpirome was highly active against aerobic gram-negative bacilli including Acinetobacter spp., and the Enterobacteriaceae. Only imipenem was more active than cefpirome against Pseudomonas aeruginosa. Cefp...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238433

    authors: Rolston K,Alvarez ME,Hoy JF,LeBlanc B,Ho DH,Bodey GP

    更新日期:1986-01-01 00:00:00

  • In vitro activity of A-56619 and A-56620 against multi-resistant and routine clinical isolates.

    abstract::A-56619 and A-56620 are two new quinolone compounds that are currently being studied. They were found to be active against multi-resistant and routine isolates of Staphylococcus aureus, enterobacteria, aminoglycoside-sensitive and resistant strains of Pseudomonas aeruginosa. Most of the enterobacteria were inhibited b...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238573

    authors: Fernandes CJ,Wilson RD,Ackerman VP

    更新日期:1988-01-01 00:00:00

  • In vitro and in vivo antibacterial activities of AM-1155 in the fields of obstetrics and gynecology.

    abstract::AM-1155 is a new 8-methoxyquinolonecarboxylic acid with a broad spectrum of antibacterial activity. It inhibited more than 90% of clinical isolates of Streptococcus agalactiae, Escherichia coli, Peptostreptococcus magnus, Bacteroides fragilis and Prevotella bivia at the concentration of 3.13 mg/l. The antibacterial ac...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007120

    authors: Mikamo H,Kawazoe K,Sato Y,Hayasaki Y,Izumi K,Tamaya T

    更新日期:1998-07-01 00:00:00

  • Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.

    abstract:BACKGROUND:An ethylacetate-soluble fraction (ET4) from the lichen Ramalina farinacea has previously been shown to inhibit the infectivity of lentiviral and adenoviral vectors, as well as wild-type HIV-1. We now determined the antiviral activity of ET4 against other wild-type viruses, including the herpes simplex virus ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000194974

    authors: Esimone CO,Grunwald T,Nworu CS,Kuate S,Proksch P,Uberla K

    更新日期:2009-01-01 00:00:00

  • Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.

    abstract::100 febrile patients with chemotherapy-induced neutropenia (less than 0.5 x 10(9)/l) were empirically treated by ceftriaxone (2 g daily in adults, 50 mg/kg daily in children, as a once daily injection) and amikacin (15-20 mg/kg daily). The mean age was 41 years (range 8-72). 51 patients had acute leukemia, 29 non-Hodg...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238883

    authors: Blanc C,Pollet JP,Bauters F

    更新日期:1991-01-01 00:00:00

  • A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents.

    abstract::The in vitro activity of fleroxacin was determined by broth microdilution against 2,079 recent bacterial isolates and compared to the activities of ciprofloxacin, ofloxacin, lomefloxacin, cefaclor, cefuroxime, cefixime, ceftriaxone, amoxicillin/clavulanate, trimethoprim/sulfamethoxazole (TMP-SMX), and, as appropriate,...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000239386

    authors: Markowitz SM,Williams DS,Hanna CB,Parker JL,Pierce MA,Steele JC Jr

    更新日期:1995-11-01 00:00:00

  • Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers.

    abstract::Gemifloxacin is a novel fluoroquinolone with a broad spectrum of activity. This double-blind, randomized, parallel-group study was designed to demonstrate the lack of effect of steady-state concentrations of gemifloxacin on the pharmacodynamic effects of warfarin. Healthy male subjects received loading doses of warfar...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000007243

    authors: Davy M,Bird N,Rost KL,Fuder H

    更新日期:1999-11-01 00:00:00

  • Effect of linezolid on the phagocytic functions of human polymorphonuclear leukocytes.

    abstract::The effect of linezolid on the phagocytic and bactericidal functions of human polymorphonuclear neutrophils (PMN) against gram-positive cocci was evaluated. Preincubation (30 min; 37 degrees C) of PMN with different concentrations of linezolid (2, 10 and 20 mg/l) did not significantly affect the phagocytosis of either...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000071139

    authors: Ballesta S,Pascual A,García I,Perea EJ

    更新日期:2003-07-01 00:00:00

  • In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.

    abstract::Treatment of enterococcal infections is often difficult because of intrinsic and acquired resistance to a variety of antimicrobial agents. Between January 1993 and May 1997, enterococci were isolated from blood cultures of 117 patients at the Institute of Medical Microbiology and Immunology, University Hospital Eppend...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007263

    authors: Elsner HA,Sobottka I,Feucht HH,Claussen M,Kaulfers PM,Laufs R,Mack D

    更新日期:2000-03-01 00:00:00

  • Preventive effects of trimethoprim/sulphamethoxazole on experimental staphylococcic pyelonephritis in rats.

    abstract::108 white rats weighing 170-250 G were given trimethoprim, sulphamethoxazole and the combination trimethoprim 1/sulphamethoxazole orally and parenterally in order to test the preventive effect of these substances on experimental hematogenous pyelonephritis due to Staphylococcus aureus. Oral applications of 48 mg/kg/24...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221848

    authors: Obek A,Anğ O,Iplikçi A,Güvener Z,Eroğlu L,Güngör M,Yurtkuran M

    更新日期:1975-01-01 00:00:00

  • Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.

    abstract:BACKGROUND:Levofloxacin and tobramycin, alone and in combination with cefepime, were investigated for their in vitro activities and post-antibiotic effects (PAEs) on Pseudomonas aeruginosa. METHODS:The in vitro activities of tobramycin and levofloxacin in combination with cefepime were determined by microbroth chequer...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000265128

    authors: Ozbek B,Otuk G

    更新日期:2009-01-01 00:00:00

  • Biliary excretion of tetroxoprim in man.

    abstract::The biliary excretion of tetroxoprim (TXP) was studied in 10 patients with T-tube drainage. A mean biliary peak of 32.56 +/- 7.69 micrograms/ml was observed 2-3 h after a single oral dose of 200 mg. The biliary elimination rate constant (kb) of TXP was found to be 0;056 (h-1), indicating a longer elimination from the ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238097

    authors: Vergin H,Luber P

    更新日期:1982-01-01 00:00:00

  • Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.

    abstract:BACKGROUND:The combination of 5-fluorouracil (5-FU), cisplatin and interferon (IFN)-alpha was found to result in a high response rate in advanced esophageal squamous cell carcinoma (SCC). METHODS:Resectable cases of esophageal SCC were treated with 3 cycles of chemotherapy consisting of cisplatin 70 mg/m(2) i.v. on da...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000151353

    authors: Bazarbashi S,Abdelsalam M,Amin T,El-Bassiouni M,Soudy H,Elweshi A,Alhusseiny H,Rehman K,Memon M,Ajarim D

    更新日期:2008-01-01 00:00:00

  • Measurement of adenine uptake as an in vitro screen for antitrichomonal agents.

    abstract::A semi-automated microdilution test was adapted for the in vitro testing of potential antitrichomonal agents. Washed cell suspensions of the pathogenic protozoan Trichomonas vaginalis were incubated in microtitration plates for 4 h at 37 degrees C in the presence radiolabelled adenine and serial dilutions of the test ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238327

    authors: Meingassner JG,Heyworth PG,Havelec L

    更新日期:1985-01-01 00:00:00

  • Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.

    abstract::Thirteen quinolone antibacterial agents were investigated as to their ability to inhibit Micrococcus luteus DNA gyrase and cell growth, and compared to those of novobiocin and coumermycin. Among the quinolones tested, the most active were found to be CI-934 and ciprofloxacin, which inhibited gyrase full supercoiling a...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238458

    authors: Fu KP,Grace ME,McCloud SJ,Gregory FJ,Hung PP

    更新日期:1986-01-01 00:00:00

  • Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.

    abstract::The intracellular activity of flurithromycin, erythromycin, roxithromycin and miocamycin against susceptible clinical isolates of Staphylococcus aureus, phagocytosed by human monocytes, was investigated. Intracellular bioactivity was studied in a 24-hour assay, using experimental conditions which allowed the intracell...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238973

    authors: Fietta A,Boeri P,Colombo ML,Merlini C,Gialdroni Grassi G

    更新日期:1993-01-01 00:00:00